Lantronix anuncia ganadores del Premio Programa de Socios de Canal SmartEdge 2024
September 06, 2024 16:48 ET
|
Lantronix, Inc.
IRVINE, California, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), líder mundial en soluciones de computación y conectividad de IoT, anunció hoy los ganadores de sus Programa de...
Lantronix Anuncia Nomes dos Vencedores da Premiação 2024 SmartEdge Channel Partner Program Award
September 06, 2024 16:48 ET
|
Lantronix, Inc.
IRVINE, Califórnia, Sept. 06, 2024 (GLOBE NEWSWIRE) -- A Lantronix Inc. (NASDAQ: LTRX), líder global de soluções de IoT de computação e conectividade, anunciou hoje os vencedores da sua...
ラントロニクス (Lantronix)、2024年スマートエッジ (SmartEdge) チャネルパートナープログラムアワード受賞者を発表
September 06, 2024 16:48 ET
|
Lantronix, Inc.
カリフォルニア州アーバイン, Sept. 07, 2024 (GLOBE NEWSWIRE) -- コンピューティングおよびコネクティビティIoTソリューションのグローバル リーダーであるラントロニクス (Lantronix Inc.) (NASDAQ: LTRX) は本日、2024年スマートエッジ (SmartEdge™)...
Lantronix Mengumumkan Pemenang Penghargaan SmartEdge Channel Partner Program 2024
September 06, 2024 16:48 ET
|
Lantronix, Inc.
IRVINE, California, Sept. 07, 2024 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), pemimpin global dalam bidang solusi IoT komputasi dan konektivitas, hari ini mengumumkan pemenang Penghargaan...
Lantronix annonce les lauréats des prix du programme de partenariat SmartEdge 2024
September 06, 2024 16:48 ET
|
Lantronix, Inc.
IRVINE, Californie, 06 sept. 2024 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ : LTRX), leader mondial des solutions IdO de calcul et de connectivité, a annoncé aujourd’hui les lauréats des prix de...
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 06, 2024 16:32 ET
|
NewAmsterdam Pharma N.V.
NAARDEN, the Netherlands and MIAMI, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering
September 06, 2024 16:30 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the closing of its previously announced public offering of 14,724,058...
Iterum Therapeutics to Present at the 26th Annual H.C. Wainwright Global Investment Conference
September 06, 2024 16:30 ET
|
Iterum Therapeutics PLC
DUBLIN, Ireland and CHICAGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next-generation oral...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 06, 2024 16:30 ET
|
ORIC Pharmaceuticals
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...
Elutia Celebrates First Year
September 06, 2024 16:23 ET
|
Elutia Inc.
Company Thanks Stakeholders and Employees for a Year of Remarkable Growth and Accomplishment SILVER SPRING, Md., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer...